Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidy
Open Access
- 13 January 2009
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 19 (2), 276-283
- https://doi.org/10.1101/gr.075671.107
Abstract
Microarrays are frequently used to profile genome-wide copy number (CN) aberrations. While generally robust for detecting CN variants in germline DNA, the methods used to derive CN from signal intensity values have been suboptimal when applied to cancer genomes. The complexity of genomic aberrations in cancer makes it more difficult to discriminate between signal and noise, and measuring CN as a discrete variable does not account for tumor heterogeneity. Furthermore, standard normalization approaches detect CN changes relative to the overall DNA content, which is often not diploid in cancer. We propose an algorithm that uses the degree of allelic imbalance as well as probe intensity, with a correction for aneuploidy, for a quantitative CN assessment and scoring of allelic ratios. This algorithm results in a more precise definition of CN and allelic aberration in the cancer genome, which is essential for translational efforts focused on using these tools for molecular diagnostics and for the discovery of therapeutic targets.Keywords
This publication has 26 references indexed in Scilit:
- Circular binary segmentation for the analysis of array-based DNA copy number dataBiostatistics, 2004
- An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism ArraysCancer Research, 2004
- Acute Lymphoblastic LeukemiaThe New England Journal of Medicine, 2004
- High-Resolution Analysis of DNA Copy Number Using Oligonucleotide MicroarraysGenome Research, 2004
- Large-scale genotyping of complex DNANature Biotechnology, 2003
- Genomic microarrays in human genetic disease and cancerHuman Molecular Genetics, 2003
- Detection of MYCN Gene Amplification in Neuroblastoma by Fluorescence In Situ Hybridization: A Pediatric Oncology Group StudyNeoplasia, 2001
- Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene.1988
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasThe New England Journal of Medicine, 1985
- Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of NeuroblastomasJNCI Journal of the National Cancer Institute, 1984